Your browser doesn't support javascript.
Explaining demographic differences in COVID-19 vaccination stage in the United States - April-May 2021.
Huang, Qian; Abad, Neetu; Bonner, Kimberly E; Baack, Brittney; Petrin, Robert; Hendrich, Megan A; Lewis, Zachary; Brewer, Noel T.
  • Huang Q; Department of Health Behavior, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA. Electronic address: qhuang@unc.edu.
  • Abad N; Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Bonner KE; Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Baack B; Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Petrin R; Ipsos US Public Affairs, Washington, DC, USA.
  • Hendrich MA; Ipsos US Public Affairs, Washington, DC, USA.
  • Lewis Z; Ipsos US Public Affairs, Washington, DC, USA.
  • Brewer NT; Department of Health Behavior, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
Prev Med ; : 107341, 2022 Nov 10.
Article in English | MEDLINE | ID: covidwho-2241577
ABSTRACT
COVID-19 vaccine coverage in the US has marked demographic and geographical disparities, but few explanations exist for them. Our paper aimed to identify behavioral and social drivers that explain these vaccination disparities. Participants were a national sample of 3562 American adults, recruited from the Ipsos KnowledgePanel. Participants completed an online survey in spring 2021, when COVD-19 vaccination was available for higher-risk groups but not yet available to all US adults. The survey assessed COVID-19 vaccination stage (intentions and vaccine uptake), constructs from the Increasing Vaccination Model (IVM) domains (thinking and feeling, social processes, and direct behavior change), self-reported exposure to COVID-19 vaccine information, and demographic characteristics. Analyses used multiple imputation to address item nonresponse and linear regressions to conduct mediation analyses. Higher COVID-19 vaccination stage was strongly associated with older age, liberal political ideology, and higher income in adjusted analyses (all p < .001). Vaccination stage was more modestly associated with urbanicity, white race, and Hispanic ethnicity (all p < .05). Some key mediators that explained more than one-third of demographic differences in vaccination stage were perceived vaccine effectiveness, social norms, and recommendations from family and friends across most demographic characteristics (all p < .05). Other mediators included safety concerns, trust, altruism, provider recommendation, and information seeking. Access to vaccination, barriers to vaccination, and self-efficacy explained few demographic differences. One of the most reliable explanations for demographic differences in COVID-19 vaccination stage is social processes, including social norms, recommendations, and altruism. Interventions to promote COVID-19 vaccination should address social processes and other domains in the IVM.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Language: English Journal: Prev Med Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Language: English Journal: Prev Med Year: 2022 Document Type: Article